Avant Brands Inc. (AVNT.TO)
CAD 0.53
(1.92%)
CAD 0.53
(1.92%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -5.07 Million CAD | 32.78% |
| 2022 | -7.54 Million CAD | 40.54% |
| 2021 | -11.23 Million CAD | -14.23% |
| 2020 | -10.17 Million CAD | -1.78% |
| 2019 | -9.76 Million CAD | 9.06% |
| 2018 | -10.52 Million CAD | -469.83% |
| 2017 | -1.84 Million CAD | -794.41% |
| 2016 | -206.56 Thousand CAD | -503.14% |
| 2015 | 51.23 Thousand CAD | 107.88% |
| 2014 | -650.18 Thousand CAD | -288.96% |
| 2013 | -167.15 Thousand CAD | -984.53% |
| 2012 | -15.41 Thousand CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -2.75 Million CAD | 50.59% |
| 2024 Q2 | -3.73 Million CAD | -35.66% |
| 2024 Q3 | -2.94 Million CAD | 21.09% |
| 2023 Q4 | -5.56 Million CAD | -698.07% |
| 2023 Q1 | -91 Thousand CAD | 98.21% |
| 2023 FY | -5.07 Million CAD | 23.39% |
| 2023 Q2 | -418 Thousand CAD | -359.34% |
| 2023 Q3 | 931 Thousand CAD | 322.73% |
| 2022 FY | -6.61 Million CAD | 40.54% |
| 2022 Q3 | 4.59 Million CAD | 242.97% |
| 2022 Q4 | -6.69 Million CAD | -245.65% |
| 2022 Q1 | -520 Thousand CAD | 93.24% |
| 2022 Q2 | -3.21 Million CAD | -518.46% |
| 2021 Q3 | -2.68 Million CAD | -60.38% |
| 2021 FY | -11.13 Million CAD | -14.23% |
| 2021 Q4 | -7.68 Million CAD | -185.97% |
| 2021 Q2 | -1.67 Million CAD | -305.64% |
| 2021 Q1 | 815 Thousand CAD | 110.27% |
| 2020 FY | -9.74 Million CAD | -1.78% |
| 2020 Q1 | -1.18 Million CAD | 49.85% |
| 2020 Q2 | -778 Thousand CAD | 34.12% |
| 2020 Q3 | -280 Thousand CAD | 64.01% |
| 2020 Q4 | -7.93 Million CAD | -2733.21% |
| 2019 Q3 | -2.24 Million CAD | 2.73% |
| 2019 Q1 | -2.85 Million CAD | 13.1% |
| 2019 Q2 | -2.31 Million CAD | 19.14% |
| 2019 Q4 | -2.35 Million CAD | -4.81% |
| 2019 FY | -9.57 Million CAD | 9.06% |
| 2018 Q2 | -1.48 Million CAD | -16746.68% |
| 2018 Q3 | -2.47 Million CAD | -66.52% |
| 2018 FY | -10.52 Million CAD | -469.83% |
| 2018 Q4 | -3.28 Million CAD | -32.67% |
| 2018 Q1 | -8833.00 CAD | -161.1% |
| 2017 Q1 | -3129.00 CAD | 98.21% |
| 2017 Q4 | 14.45 Thousand CAD | 142.86% |
| 2017 Q3 | -33.72 Thousand CAD | -1530.21% |
| 2017 Q2 | -2069.00 CAD | 33.88% |
| 2017 FY | -1.84 Million CAD | -794.41% |
| 2016 FY | -206.56 Thousand CAD | -503.14% |
| 2016 Q2 | -9668.00 CAD | 28.38% |
| 2016 Q1 | -13.49 Thousand CAD | 3.52% |
| 2016 Q4 | -174.79 Thousand CAD | -1931.73% |
| 2016 Q3 | -8603.00 CAD | 11.02% |
| 2015 FY | 51.23 Thousand CAD | 107.88% |
| 2015 Q3 | -45.37 Thousand CAD | -138.9% |
| 2015 Q1 | -6026.00 CAD | 98.78% |
| 2015 Q2 | 116.62 Thousand CAD | 2035.4% |
| 2015 Q4 | -13.99 Thousand CAD | 69.16% |
| 2014 Q3 | -69.23 Thousand CAD | -117.69% |
| 2014 Q1 | -57.22 Thousand CAD | 59.63% |
| 2014 FY | -650.18 Thousand CAD | -288.96% |
| 2014 Q4 | -491.92 Thousand CAD | -610.48% |
| 2014 Q2 | -31.8 Thousand CAD | 44.42% |
| 2013 Q1 | -2101.00 CAD | 0.0% |
| 2013 FY | -167.15 Thousand CAD | -984.53% |
| 2013 Q2 | - CAD | 100.0% |
| 2013 Q3 | -23.32 Thousand CAD | 0.0% |
| 2013 Q4 | -141.73 Thousand CAD | -507.67% |
| 2012 FY | -15.41 Thousand CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Aurora Cannabis Inc. | -69.32 Million CAD | 92.687% |
| Avicanna Inc. | -8.74 Million CAD | 42.011% |
| Cardiol Therapeutics Inc. | -28.12 Million CAD | 81.975% |
| Crescita Therapeutics Inc. | -1.98 Million CAD | -155.287% |
| Knight Therapeutics Inc. | -16.83 Million CAD | 69.884% |
| MediPharm Labs Corp. | -13.08 Million CAD | 61.247% |
| OrganiGram Holdings Inc. | -229.47 Million CAD | 97.791% |
| Canopy Growth Corporation | -657.26 Million CAD | 99.229% |
| Willow Biosciences Inc. | -13.02 Million CAD | 61.087% |
| Auxly Cannabis Group Inc. | -44.51 Million CAD | 88.61% |